Please use this identifier to cite or link to this item: https://doi.org/10.1016/S0006-3223(01)01076-9
Title: Susceptibility to neuroleptic-induced tardive dyskinesia and the T102C polymorphism in the serotonin type 2A receptor
Authors: Tan, E.-C.
Chong, S.-A.
Mahendran, R.
DONG FANG 
Tan, C.-H.
Keywords: Polymorphism
Schizophrenia
Serotonin receptor gene
Tardive dyskinesia
Issue Date: 15-Jul-2001
Citation: Tan, E.-C., Chong, S.-A., Mahendran, R., DONG FANG, Tan, C.-H. (2001-07-15). Susceptibility to neuroleptic-induced tardive dyskinesia and the T102C polymorphism in the serotonin type 2A receptor. Biological Psychiatry 50 (2) : 144-147. ScholarBank@NUS Repository. https://doi.org/10.1016/S0006-3223(01)01076-9
Abstract: Background: Genetic factors have been implicated in the pathophysiology of the movement disorder tardive dyskinesia, which may involve dopamine-serotonin interaction. Case-control association studies have identified the T102C polymorphism of the 5-HT2A receptor gene as being associated with schizophrenia and responsiveness to clozapine. In this study, we examine the association of this polymorphism in the 5-HT2A receptor gene as a risk factor for developing schizophrenia and tardive dyskinesia from prolonged treatment with neuroleptics. Methods: Ninety-seven healthy control subjects with no history of mental illness and 221 schizophrenic patients (87 with tardive dyskinesia, 134 without) were genotyped by PCR-RFLP. Results: Comparison between cases and control subjects revealed no significant association between the C allele and schizophrenia. There was significant difference in allele frequency (p = .044, OR = 1.54 95% CI = 1.02-2.33) between patients who developed tardive dyskinesia and those who did not. Significant difference remains even after adjusting for age and neuroleptic dosage (p = .041) with the odds ratio at 1.64 (95% CI = 1.02-2.62). Conclusions: A genetic variant of the 5-HT2A receptor may be associated with neuroleptic-induced tardive dyskinesia in schizophrenia. Further studies are needed to replicate the finding. The role of 5-HT2A receptor in the etiology of tardive dyskinesia or treatment-resistant schizophrenia should be further investigated. © 2001 Society of Biological Psychiatry.
Source Title: Biological Psychiatry
URI: http://scholarbank.nus.edu.sg/handle/10635/112812
ISSN: 00063223
DOI: 10.1016/S0006-3223(01)01076-9
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

74
checked on Dec 10, 2018

WEB OF SCIENCETM
Citations

64
checked on Dec 10, 2018

Page view(s)

32
checked on Dec 14, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.